BLUE LAKE BIOTECHNOLOGY
Blue Lake Biotechnology is a startup company that focuses on developing a human vaccine using a novel viral vector. Its goal is to develop PIV5-based vaccines for human disease with an initial focus on the respiratory syncytial virus, as well as obtain the FDA’s approval for phase I trial. The company is located in Athens, Georgia and was founded in 2019 by Biao He.
BLUE LAKE BIOTECHNOLOGY
Industry:
Biotechnology Health Care Life Science
Founded:
2019-01-01
Address:
Athens, Georgia, United States
Country:
United States
Website Url:
http://www.bluelakebiotechnology.com
Total Employee:
1+
Status:
Active
Contact:
+1 706 201 7798
Total Funding:
8.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail COVID-19 Typekit
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.bluelakebiotechnology.com Semrush global rank: 5.42 M Semrush visits lastest month: 1.56 K
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Blue Lake Biotechnology"
Blue Lake Biotechnology to Be Featured at the Biotechnology …
May 31, 2023 Athens, GA and Los Gatos, CA – May 31, 2023 - Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company harnessing the full breadth of the immune system to …See details»
Blue Lake Biotechnology - Crunchbase Company …
Blue Lake Biotechnology is a startup company that focuses on developing a human vaccine using a novel viral vector. Its goal is to develop PIV5-based vaccines for human disease with an initial focus on the respiratory syncytial …See details»
Our Team - Blue Lake Biotechnology
Helen has over 25 years of experience in accounting and finance in the healthcare industry. She has previously served as CFO and Controller for Cardiovascular Clinical Sciences, a full …See details»
Blue Lake Biotechnology to Be Featured at the Biotechnology …
May 31, 2023 Learn more at https://www.bluelakebiotechnology.com. CONTACTS: Carolyn Hawley Evoke Canale [email protected] 619-849-5382. Samuel Wu, Chief Business Officer …See details»
Blue Lake Biotechnology | LinkedIn
Blue Lake Biotechnology is an intranasal vaccine company enlisting the full force of the immune system to keep people healthy, prevent serious infectious diseases, and save the lives of vulnerable ...See details»
Blue Lake Biotechnology to Be Featured at the Biotechnology
May 31, 2023 Blue Lake Biotechnology, Inc. announced that company CEO Biao He, Ph.D., will present and host one-on-one partnering meetings at the 2023 Biotechnology Innovation …See details»
Blue Lake Biotechnology to Be Featured at the Biotechnology …
May 31, 2023 Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company harnessing the full breadth of the immune system to protect against serious infectious …See details»
Blue Lake Biotechnology Presenting at Upcoming …
Sep 27, 2023 Contacts. Carolyn Hawley Evoke Canale [email protected] 619-849-5382 Samuel Wu, Chief Business Officer Blue Lake Biotechnology, Inc. and CyanVac LLC …See details»
News - Blue Lake Biotechnology
Jun 29, 2023 [email protected] 650-609-2231 . Read More. ... Ph.D., will present and host one-on-one partnering meetings at the 2023 Biotechnology Innovation …See details»
Blue Lake Biotechnology Reports Positive Interim Clinical Data in ...
Mar 21, 2024 ATHENS, Ga. & SAN JOSE, Calif., March 21, 2024--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5) …See details»
Blue Lake Biotechnology Doses First Child in Clinical Trial of Novel ...
Jun 29, 2023 Learn more at https://www.bluelakebiotechnology.com. CONTACTS: Carolyn Hawley Evoke Canale [email protected] 619-849-5382. Samuel Wu, Chief Business Officer …See details»
Positive Phase 1 Data for Blue Lake Biotechnology’s Intranasal RSV ...
Oct 25, 2023 Samuel Wu, Chief Business Officer Blue Lake Biotechnology, Inc. and CyanVac LLC [email protected] 650-609-2231 Contacts Carolyn Hawley Evoke Canale …See details»
Blue Lake Biotechnology Announces First Participant Dosed in a …
Jul 21, 2022 Learn more at https://www.bluelakebiotechnology.com. Forward Looking Statements. This press release contains forward-looking statements, including with respect to …See details»
Blue Lake Biotechnology Reports Positive Interim Clinical Data in ...
Mar 21, 2024 ATHENS, Ga. & SAN JOSE, Calif.--(BUSINESS WIRE)-- Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza …See details»
Our Platform - Blue Lake Biotechnology
Robust Immune Responses. In preclinical studies, we have shown that our vaccines robustly produce three forms of immunity: Cellular immunity: Cellular immunity is essential for fighting …See details»
Blue Lake Biotechnology Announces First Participant Dosed in
Jul 21, 2022 ATHENS, Ga. and LOS GATOS, Calif., July 21, 2022 /PRNewswire/ -- Blue Lake Biotechnology, Inc., a clinical-stage biotechnology company developing vaccines using a …See details»
Blue Lake Biotechnology Doses First Child in Clinical Trial of Novel ...
Jun 29, 2023 Athens, GA and Los Gatos, CA, June 29, 2023 - Blue Lake Biotechnology, Inc., a clinical stage intranasal vaccine company harnessing the full breadth of the immune system to …See details»
Blue Lake Biotechnology Announces Positive Interim Phase 1 Data …
Nov 7, 2022 Learn more at https://www.bluelakebiotechnology.com. Forward Looking Statements. This press release contains forward-looking statements, including with respect to …See details»
Blue Lake and CyanVac Report Positive Phase 2a Data for …
Nov 25, 2024 Athens, Ga. and San Jose, Calif., November 25, 2024 – Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5) …See details»